Table 1. Characteristics (absolute numbers and relevant proportions) of the study population by arm and overall combined.
| Arm A | Arm B | Arm C | Totals | |||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | |
| Number seen at site (fully screened) | 13,906 | 11,787 | 23,863 | 49,556 | ||||
| Number female | 8,552 | 61.5% | 7,282 | 61.8% | 14,252 | 59.7% | 30,086 | 60.7% |
| Age group | ||||||||
| 15–24 years | 5,056 | 36.4% | 4,417 | 37.5% | 9,114 | 38.2% | 18,587 | 37.5% |
| 25–34 years | 3,639 | 26.2% | 2,930 | 24.9% | 6,073 | 25.4% | 12,642 | 25.5% |
| 35–44 years | 2,357 | 16.9% | 1,995 | 16.9% | 3,866 | 16.2% | 8,218 | 16.6% |
| 45–54 years | 1,418 | 10.2% | 1,205 | 10.2% | 2,288 | 9.6% | 4,911 | 9.9% |
| 55+ years | 1,436 | 10.3% | 1,240 | 10.5% | 2,522 | 10.6% | 5,198 | 10.5% |
| Length of residence | ||||||||
| <1 years | 685 | 4.9% | 570 | 4.8% | 1,583 | 6.6% | 2,838 | 5.7% |
| 1–5 years | 2,984 | 21.5% | 2,528 | 21.4% | 5,594 | 23.4% | 11,106 | 22.4% |
| >5–10 years | 3,226 | 23.2% | 2,909 | 24.7% | 4,900 | 20.5% | 11,035 | 22.3% |
| >10 years | 7,011 | 50.4% | 5,780 | 49.0% | 11,786 | 49.4% | 24,577 | 49.6% |
| Education level | ||||||||
| None | 483 | 3.5% | 502 | 4.3% | 626 | 2.6% | 1,611 | 3.3% |
| Primary school | 3,412 | 24.5% | 2,750 | 23.3% | 4,791 | 20.1% | 10,953 | 22.1% |
| Secondary school | 9,405 | 67.6% | 8,060 | 68.4% | 17,276 | 72.4% | 34,741 | 70.1% |
| Higher education | 606 | 4.4% | 475 | 4.0% | 1,170 | 4.9% | 2,251 | 4.5% |
| History TB treatment | ||||||||
| Previous TB | 1,304 | 9.4% | 976 | 8.3% | 2,076 | 8.7% | 4,356 | 8.8% |
| Current TB | 128 | 0.9% | 76 | 0.6% | 91 | 0.4% | 295 | 0.6% |
| HIV status* | ||||||||
| Negative | 10,688 | 76.9% | 8,916 | 75.6% | 17,391 | 72.9% | 36,995 | 74.7% |
| Positive | 2,322 | 16.7% | 1,847 | 15.7% | 3,808 | 16.0% | 7,977 | 16.1% |
| Unknown | 896 | 6.4% | 1,024 | 8.7% | 2,664 | 11.2% | 4,584 | 9.3% |
| HIV and ART status | ||||||||
| Negative | 10,688 | 76.9% | 8,916 | 75.6% | 17,391 | 72.9% | 36,995 | 74.7% |
| Self-reported positive, on ART | 1,962 | 14.1% | 1,476 | 12.5% | 3,160 | 13.2% | 6,598 | 13.3% |
| Self-reported positive, not on ART | 151 | 1.1% | 133 | 1.1% | 285 | 1.2% | 569 | 1.1% |
| Tested HIV–positive in survey | 209 | 1.5% | 238 | 2.0% | 363 | 1.5% | 810 | 1.6% |
| Unknown | 896 | 6.4% | 1,024 | 8.7% | 2,664 | 11.2% | 4,584 | 9.3% |
* After completing TREATS study procedures so including testing done as part of TREATS.
ART, antiretroviral therapy; HIV, human immunodeficiency virus; TB, tuberculosis; TREATS, Tuberculosis Reduction through Expanded Anti-retroviral Treatment and Screening.